To examine how androgens affect endocrine events associated with increased ovulation rate, gilts were injected with androgen receptor agonists, an antagonist, or a combination of both. Blood samples were collected hourly from Day 13 to estrus (Day 0 = onset of estrus) coincident with gilts (n = 6 per treatment) receiving daily treatments of vehicle (corn oil), 10 mg of testosterone, 10 mg of 5 alpha-dihydrotestosterone (dihydrotestosterone), 1.5 g of flutamide (an androgen receptor antagonist), testosterone plus flutamide, or dihydrotestosterone plus flutamide. Treatment of gilts with testosterone or dihydrotestosterone alone increased (P , 0.05) concentrations of FSH in serum, and these effects were blocked by cotreatment with flutamide. Estradiol-17beta and androstenedione concentrations in serum were increased (P , 0.05) at 2 h after injection of testosterone or testosterone plus flutamide but not after dihydrotestosterone treatment, probably because of the role of testosterone as a substrate for estradiol-17beta and androstenedione synthesis. There were no effects of the six treatments on serum concentrations of progesterone during luteolysis, but treating gilts with testosterone shortened (P , 0.05) the proestrous period. Total embryonic loss by Day 11 in gilts treated with dihydrotestosterone was reversed when gilts were cotreated with dihydrotestosterone plus flutamide. Results of this experiment indicated that androgen actions both increased FSH secretion and reduced embryonic survival by a mechanism(s) dependent on the androgen receptor.
INTRODUCTION
Ovulation rate (OR), a factor important to litter size in swine [1] , is affected by the number of follicles recruited and the number of follicles that undergo atresia. Follicular recruitment appears to be controlled mainly by FSH [2, 3] , while FSH and LH are requisite for the final growth and steroidogenesis of pig follicles [4] . Testosterone serves as substrate for the synthesis of androstenedione and estradiol-17b in pig follicles [5] . Estradiol-17b is related to the health of the follicle [6] and induces estrous behavior. These hormones, along with other signals, interact in a complex manner to regulate the growth and ovulation of follicles.
Although androgens in females of various species have been associated with altering gonadotropins and ovarian steroids, the published effects are not consistent. For example, secretion of LH and progesterone was increased by immunizing ewes [7, 8] and gilts [9] against androstenedione. In contrast, exogenous testosterone increased FSH secretion in female rats [10] and ewes [11] , hypothetically through the conversion of testosterone to estradiol-17b. Recently, Burger et al. [12] observed that female rats implanted with 5a-dihydrotestosterone (DHT) had increased concentrations of FSH in their serum as compared to vehicle-or testosterone-treated animals. However, treating rats with DHT decreased OR without altering FSH or LH secretions [13] . Our laboratory has demonstrated that androgens can increase OR [14, 15] and litter size [16] in pigs.
The increase in OR observed in gilts after androgen treatment might be due in part to enhanced follicular development through proliferation of granulosa cells and/or augmenting responsiveness of follicular cells to gonadotropins [17] [18] [19] . Alternatively, the increase in OR after androgen treatment of gilts might be related to changes in gonadotropin or ovarian steroid secretion. In this experiment, the latter was investigated: how exogenous androgens affect serum concentrations of gonadotropins and ovarian steroids.
MATERIALS AND METHODS
Crossbred gilts obtained from the university herd were observed in pens for estrus, twice daily with boars. Animals were included in the experiment if the duration of two consecutive estrous cycles was between 19.5 and 20.5 days (Day 0 ¼ onset of estrus). Thirty-six gilts were assigned randomly to one of six treatments (n ¼ 6 per treatment): vehicle (corn oil), testosterone (10 mg/day), DHT (10 mg/day), flutamide (1.5 g/day), testosterone plus flutamide, and DHT plus flutamide. Treatments (intramuscular injections) were given daily at 0800 h from Day 13 and continued until the onset of the next estrus. Dosages of androgens were previously observed in our laboratory to increase OR in gilts [14, 15] . The dosage of flutamide utilized to block the AR was similar, on a per-kilogram-of-body-weight basis, to that used in rats [20] . Testosterone and DHT were dissolved and flutamide was suspended in vehicle before injection into the muscular tissue. Animals treated with flutamide did not enter the food chain.
A cannula was placed into a jugular vein of each gilt on Day 9. Following cannulation procedures, a period of 4 days was allowed for the gilts to adapt to being moved into individual stalls. On Day 13, blood was sampled hourly (5-10 ml, depending on how many hormones were assayed at that time) and continued until the onset of estrus. For gilts due to be sampled at 0800 h, blood samples were collected immediately before the daily hormone treatments. Blood was allowed to clot at 48C and resulting serum stored at À208C until analysis.
Gilts were temporarily removed twice a day from their stalls for estrous detection with intact boars. When gilts came into estrus, the cannulas were removed and gilts mated to different boars, 12 and 24 h later. Subsequently, an ovariohysterectomy was performed on Day 11 for purposes of counting the number of corpora lutea and concepti. Concepti were recovered by flushing the uterus with a saline solution (0.9%, w/v, sodium chloride). All procedures were approved and supervised by The Ohio State University, College of Food, Agriculture and Environmental Sciences Animal Care and Use Committee. Gonadotropins in serum were quantified by double antibody RIA (modification of Acosta et al. [21] ). Purified FSH (AFP-10640B) and LH (AFP-11043B) from pigs and antisera (AFP-2062096 and AFP-15103194 for FSH and LH, respectively) were purchased from A.F. Parlow (National Hormone and Peptide Program, Torrance, CA). For FSH determination, the standard curve consisted of 1.0-40.0 ng/ml, while LH consisted of 0.25-20.0 ng/ml. Antisera were diluted to 1:400 000 and 1:3 000 000 (final dilutions in assay tubes) for FSH and LH, respectively. The second antibody (goat-antirabbit IgG obtained from Lampire Biological Laboratories, Pipersville, PA) was diluted 1:32 and 1:20 for FSH and LH, respectively. The sensitivity was 0.20 and 0.17 ng/ml for FSH and LH, respectively. The inter-and intra-assay coefficients of variation (CVs) for a sample containing 3.5 ng FSH/ml were 5.5% and 7.8%, respectively; for a sample containing 0.90 ng/ml, these values were 14.5% and 14.7%, respectively. The inter-and intra-assay CVs for a sample containing 4.6 ng LH/ml were 7.2% and 15.7%, respectively; for a sample containing 1.6 ng/ml, these values were 6.2% and 9.4%, respectively.
The concentrations of estradiol-17b were determined by a single antibody RIA (modification of Anderson et al. [22] ). The standard curve ranged from 2.0 to 50.0 pg/ml. The sensitivity was 1.1 pg/ml. The inter-and intra-assay CVs for a sample containing 10.5 pg/ml were 7.4% and 13.6%, respectively; for a sample containing 23.5 pg/ml, these values were 10.0% and 11.5%, respectively.
Progesterone, testosterone, and androstenedione were analyzed using commercial kits (Coat-A-Count Progesterone, Coat-A-Count Total Testosterone, and Coat-A-Count Direct Androstenedione, all obtained from Diagnostic Products Corporation [DPC], Los Angeles, CA). For the analysis of progesterone, a parallelism test indicated that serum samples needed to be diluted; therefore, 50 ll of PBS containing 0.1% gelatin (PBS-Gel) were added to 50 ll of serum. Subsequently, manufacturer procedures were followed. The sensitivity (given by the manufacturer) was 0.02 ng/ml. The inter-and intraassay CVs for a sample containing 18.6 ng/ml were 4.1% and 3.4%, respectively; for a sample containing 1.1 ng/ml, these values were 4.3% and 15.1%, respectively. For the analysis of testosterone, 500 ll of serum samples were extracted as previously described for estradiol-17b analysis [23] . Samples were reconstituted with 60 ll of testosterone matrix calibrator (Total Testosterone Matrix Calibrator, DPC). Subsequently, manufacturer procedures were followed. The sensitivity (given by the manufacturer) was 0.04 ng/ml. The inter-and intra-assay CVs for a sample containing 14.1 ng/ml were 8.8% and 16.5%, respectively; for a sample containing 0.2 ng/ml, these values were 8.4% and 12.9%, respectively. Androstenedione was analyzed similar to testosterone with the modification that standards were also extracted and 110 ll of PBS-Gel were utilized for reconstitution of the samples. Subsequently, manufacturer procedures were followed. The sensitivity (given by the manufacturer) was 0.04 ng/ml. The inter-and intra-assay CVs for a sample containing 11.4 ng/ml were 4.8% and 3.7%, respectively; for a sample containing 0.6 ng/ml, these values were 8.5% and 3.1%, respectively.
The concentrations of FSH in serum were analyzed in samples collected every other hour because of its slower pulsatile nature than LH, which was analyzed in each hourly sample. Progesterone, estradiol-17b, and testosterone change concentrations in peripheral blood slowly and were analyzed at 0 and þ12 h (0 h ¼ 0800 h). Additionally, estradiol-17b and androstenedione, being products of testosterone metabolism, were monitored at 1000 h (þ2 h after testosterone injection) in all gilts to examine if exogenous testosterone affected these two metabolites. Gilts began exhibiting estrus on Day 18, and to avoid the increase in LH concentrations associated with preovulatory surge and to be consistent, all hormonal changes were analyzed from Days 13 through 17. One gilt treated with testosterone was removed from the experiment because her serum concentration of progesterone on Day 13.0 was significantly lower (9.8 ng/ml) than the rest of the animals (32.0 6 6.9 ng/ml) and was determined to be undergoing luteolysis prematurely. In addition, progesterone concentrations in the serum for this gilt were below 2 ng/ml on Day 14.0, and she began displaying estrus on Day 17.0.
Heteroscedastic data (determined by use of Levene test) were logarithmically transformed to remove heterogeneity of variance for the gonadotropins, progesterone, testosterone, and androstenedione, and untransformed means are presented. Hormonal observations were subject to repeated-measures analysis of variance. The model included treatment, day, and hour as main effects and all interactions for the gonadotropins, progesterone, and androstenedione data. Concentrations of estradiol-17b were still heterogeneous after transformation, so each time (0, þ2, and þ12 h) was analyzed in separate ANOVAs (withinhour observations were not heterogeneous). For illustration purposes and because there were no hour 3 day interactions, daily means of FSH and LH concentrations are presented instead of every other hour and hourly, respectively. Therefore, each ''daily mean concentration'' of FSH and LH in serum represented the mean of 12 and 24 samples, respectively. The secretion of gonadotropins in gilts is not as episodic as females of other species, and illustrating daily means of FSH and LH is consistent with previous investigations with pigs [24, 25] . Differences in length of the estrous cycle, length of proestrus (from day when progesterone concentrations during luteolysis were less than 2 ng/ml until the onset of estrus), and number of corpora lutea were determined by utilizing one-way ANOVA and means compared by utilizing least-significant-difference tests. No statistical analysis was conducted for embryonic survival data, as no embryos were recovered from gilts in one treatment group (no variance). The data analyses for this paper were generated using SAS/GLM software, Version 9.1, of the SAS System for Windows (SAS Institute, Inc., Cary, NC).
RESULTS
Serum concentrations of gonadotropins and ovarian steroids at 0800 h on Day 13 (just before the first injections) were not different (P . 0.05) among all treatment groups. Gilts treated with either DHT or testosterone alone had greater (P , 0.05) mean concentrations of FSH in serum (no interactions, only treatment effects; Fig. 1 ) than gilts in the other treatment groups. This increase represented a 29% and 39% elevation in FSH concentrations, across days, for gilts treated with DHT (1.68 6 0.03 ng/ml) and testosterone (1.81 6 0.03 ng/ml), respectively, above gilts treated with vehicle (1.30 6 0.03 ng/ ml). Treatment with DHT plus flutamide resulted in FSH concentrations that were not different than gilts treated with vehicle and were less (P , 0.05) than gilts treated with DHT alone. This antagonistic effect of flutamide on the effects of DHT on FSH concentrations was also evident in gilts treated with testosterone.
Treating gilts with testosterone or DHT plus flutamide treatments had a lower daily mean concentration of LH on Day 13 when compared to gilts receiving DHT treatment ( Fig. 2 ; treatment 3 day interaction; P , 0.03 and P , 0.08, respectively), but LH in serum of gilts treated with DHT was not different from those treated with vehicle. Similarly, concentrations of LH in gilts treated with testosterone were not different from those receiving vehicle. No other differences were observed in LH concentrations after Day 13.
From Days 13 through 17, mean concentrations of estradiol17b were increased (P , 0.05) in samples taken þ2 h after injecting testosterone or testosterone plus flutamide (Fig. 3) as compared to gilts treated with vehicle, flutamide, DHT, or DHT plus flutamide. However, within each day, at the 0-or 
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þ12-h samples, none of the treatments had any effect on serum concentrations of estradiol-17b.
Androstenedione concentrations were increased by testosterone or testosterone plus flutamide treatments in samples collected þ2 h (Fig. 4) , similar to changes in estradiol-17b concentrations. On Days 15 and 16, androstenedione concentrations of gilts treated with testosterone plus flutamide were lower than in gilts receiving testosterone (P , 0.05) but on both days were still greater than the other treatment groups.
Serum concentrations of progesterone did not differ among treatment groups from Days 13 through 17 (data not shown). Treatment of gilts with testosterone or testosterone plus flutamide shortened (P , 0.05) whereas treatment with DHT increased (P , 0.05) duration of proestrus relative to gilts in the vehicle group (Table 1) . Duration of the estrous cycle was shortened (P , 0.05) in gilts treated with testosterone or testosterone plus flutamide (Table 1) as compared with gilts treated with vehicle.
As expected, testosterone concentrations in serum increased 12 h after treatment of gilts with testosterone or testosterone plus flutamide (treatment 3 hour interaction, P , 0.01; data not shown). No significant changes in testosterone were observed in the remaining treatment groups. The mean concentration of testosterone for these remaining groups was 0.05 6 0.02 ng/ml from Days 13 through 17.
The OR of gilts treated with DHT but not testosterone increased (P ¼ 0.06) compared with gilts receiving vehicle (Table 1) . However, embryonic survival was negatively affected in gilts that were treated with DHT or testosterone. None or only 26.6% of the potential embryos were recovered on Day 11 in gilts receiving DHT or testosterone from Day 13 to estrus, respectively. This negative effect of androgens on embryonic survival was completely eliminated when gilts were cotreated with flutamide (Table 1) .
DISCUSSION
In the present experiment, serum concentrations of FSH were increased by injecting gilts with DHT or testosterone. In support of the effect of androgens on FSH secretion in swine, gonadotropes obtained from female rats had increased FSH secretion when treated with androgens [26] . Likewise, testosterone and DHT have been demonstrated to induce the promoter of mouse Fshb gene in Lbt2 cells (immortalized gonadotropes [27] ), to increase Fshb mRNA in the adenohypophysis of female rats [12] , and to increase the activity of GnRH neurons in ovariectomized mice [28] . 
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Serum concentrations of FSH in gilts treated with androgens plus flutamide were similar to gilts treated with vehicle. The inability of androgens to alter FSH secretion in the presence of flutamide supports an involvement of the AR in this endocrine pathway.
In the present investigation, LH was not affected by androgen treatment as compared to gilts treated with vehicle. Although androgens have a strong negative feedback on LH secretion in males [29, 30] , such effects have not been observed in mares [31] , female rats [13] , or gilts (present experiment). Androgenic effects on LH secretion might be dosage related, as treatment of ovariectomized ewes with 5 mg of DHT (once or twice daily) did not affect LH secretion, but treatment with 20 mg of DHT decreased daily concentrations of LH within 4 days [32] . Our laboratory recently demonstrated that the role of LH might be affected by androgens, as the amount of LHCGR mRNA in follicles of gilts decreased with an equivalent series of DHT treatments [33] .
Concentrations of estradiol-17b in the serum were increased 2 h after injecting testosterone, even with cotreatment with flutamide, and returned by 12 h posttreatment to concentrations similar to those in gilts in the vehicle group. Hypothetically, exogenous testosterone apparently has to be elevated above the already high intrafollicular amounts of endogenous testosterone [34] to cause detectable increases in systemic estradiol-17b secretion, and this probably occurred or was detected only, at the first 2-h (þ2 h) sampling.
At 2 h after injection of testosterone or testosterone plus flutamide, androstenedione concentrations increased compared to the other treatments. Increased exposure to androstenedione could also have increased CYP19 mRNA as in bovine granulosa cells [35] . On Days 15 and 16, concentrations of androstenedione were increased further with testosterone as compared to testosterone plus flutamide treatments. Corture et al. [36] suggested a role of the AR in stimulating the activity of hydroxysteroid (17-b) dehydrogenase, and perhaps by Days 15 to 16 exogenous testosterone increased the activity of this enzyme and also served as additional substrate.
Serum concentrations of progesterone decreased similarly from Days 13 to 17 among treatment groups. As examined under the conditions of the present experiment, androgens apparently have no role in the rate of luteolysis in pigs. By contrast, in ewes, Cooke and Benhaj [37] suggested a role of testosterone in luteolysis, as they observed an increase in plasma concentrations of testosterone at the beginning of luteolysis and a delay of luteolysis when testosterone was suppressed. These differences in androgen actions might represent differences in the role of estrogens, from exogenous testosterone, on luteolysis in gilts versus ewes.
Duration of the estrous cycle was shortened when treatment of gilts included testosterone alone or in combination with flutamide. Treating gilts with testosterone increased estradiol17b and shortened proestrus, so it is suggested that perhaps relatively small increases in estradiol-17b in the systemic circulation, or direct aromatization of testosterone within the brain [38] , enhanced an earlier display of estrus. Although exogenous estrogens can lengthen or shorten the estrous cycle of gilts [39, 40] , the mechanism(s) by which exogenous estrogens or androgens shorten the estrous cycle has not been extensively investigated.
It is difficult in the present experiment to make inferences regarding OR with six animals per group. Previously, we observed with a larger sample size a larger OR with DHT versus testosterone treatments [14, 15] , probably because the AR has a higher affinity for DHT than testosterone [41] . The same trend was noted in the present experiment; DHT increased, whereas testosterone failed to alter OR from that observed in gilts treated with vehicle. Treating gilts with testosterone increased FSH secretion but did not increase ovulation rate. Perhaps by decreasing the period of proestrus, exogenous testosterone shortened the duration of follicular exposure to FSH. Noteworthy was the inability of DHT to increase OR in the presence of flutamide, supporting the involvement of the AR in this mechanism.
Although the low number of gilts per treatment in the present experiment generally would have limited our ability to access embryonic survival, the effects of androgens were pronounced and readily evident in most gilts. In the present experiment, treatment of gilts with DHT resulted in no embryonic survival to Day 11, but the presence of flutamide completely reversed these effects. Again, we suggest a role of the androgen receptor. In previous investigations, utilizing dosages of androgens that increased OR, we observed opaque uterine flushings indicative of an embryocidal environment [15] . However, effects of androgens appear dose related, as Cárdenas and Pope [42] observed that exposing gilts to small dosages of testosterone (1 mg/day) from Day 13 to estrus increased embryonic survival to Day 11. Fertilization rate does not appear to be affected in gilts treated with androgens, as a similar number of embryos were recovered 3 days after the onset of estrus from gilts treated with or without androgens [15] . Collectively, it appears that the ability of the uterus to support embryonic development might be differentially affected following moderate versus excessive exposure to androgens.
The significance of this experimentation is that treating gilts with DHT increased FSH secretion through a mechanism dependent on the androgen receptor. This increase in FSH is probably related to the increase in OR as was observed in this and previous experiments. Additionally, the androgen receptor was associated with reduction of embryonic survival. Any potential androgen therapy to further increase litter size in Means (6 SEM) within a column lacking a common superscript differed (P , 0.05). e,f Means (6 SEM) within a column lacking a common superscript differed (P , 0.05). g,h Means (6 SEM) within a column lacking a common superscript differed (P ¼ 0.06).
swine must balance stimulation of the ovary with a lack of substantial embryocidal effects.
